Dr Julie Nigro
Honorary Clinical Senior Fellow
Department of Medicine
41 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC
DOI: 10.1053/j.gastro.2025.07.0202025
Journal article
Su1880: EARLY SERUM AND FAECAL CYTOKINES PREDICT CLINICAL OUTCOMES IN ACUTE SEVERE ULCERATIVE COLITIS: RESULTS FROM PREDICT-UC
DOI: 10.1016/s0016-5085(25)02941-52025
Journal article
DOP057 Early serum and faecal cytokines predict clinical outcomes in Acute Severe Ulcerative Colitis: results from PREDICT-UC
DOI: 10.1093/ecco-jcc/jjae190.00962025
Journal article
DOP091 Early serum infliximab levels predict outcomes in Acute Severe Ulcerative Colitis: results from PREDICT-UC
DOI: 10.1093/ecco-jcc/jjae190.01302021
Journal article
Serum IL-6 is associated with treatment refractoriness in acute severe ulcerative colitis
DOI: 10.1093/ecco-jcc/jjab076.4262020
Research Contracts
Testing Immune-Mobilising Monoclonal T-Cell Receptors in Chronic Hepatitis B Patient-Derived Liver Organoids
2019
Conference Proceedings
EXPRESSION OF CD69 ON PERIPHERAL LYMPHOCYTES PREDICTS TREATMENT RESPONSE IN ACUTE SEVERE ULCERATIVE COLITIS
RECENT SCHOLARLY WORKS
2019
Journal article
Mo1876 – Expression of Cd69 on Peripheral Lymphocytes Predicts Treatment Response in Acute Severe Ulcerative Colitis
DOI: 10.1016/s0016-5085(19)39143-72019
Conference Proceedings
Expression of CD69 on peripheral lymphocytes predicts treatment response in Acute Severe ulcerative colitis
DOI: 10.1093/ecco-jcc/jjy222.1602019
Journal article
Secreted and intracellular cytokines are complementary measures for human monocytes treated with Toll-like receptor agonists
DOI: 10.1016/j.jim.2018.11.0032016
Journal article
The role of CD44 in fetal and adult hematopoietic stem cell regulation
DOI: 10.3324/haematol.2015.135921
RECENT PROJECTS
2019
Research Grant
Targetting HBV With Engineered T Cells
2018
Research Grant
Developing 3-Dimensional Hepatitis B-Liver Organoids to Screen Future Antiviral Therapeutic Targets.